Infertility Treatment Devices Market Analysis

Infertility Treatment Devices Market Analysis

The infertility treatment devices market by type is categorized into sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscopes, and others. The sperm separation devices segment garnered USD 55.4 million revenue size in the year 2022. Sperm separation devices are used in assisted reproductive treatments such as artificial insemination and in vitro fertilization (IVF). The upsurge can be attributed to its capacity to separate highly mobile sperm with competent DNA integrity from a sample of semen. Additionally, the sperm separation process removes sperms with defects such as bigger heads or twisted necks. Sperm separation arrays allow only the healthiest and most robust sperm to pass through.
 

Based on end-use, the infertility treatment devices market is segmented into fertility clinics, hospitals & other healthcare facilities, and clinical research institutes. The fertility clinics segment accounted for over 80% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. Fertility clinics have enhanced their infrastructure along with strengthening the portfolio including infertility services, thereby is anticipated to impel the segment growth. Adoption of several procedures is considerably high in fertility clinics due to substantial performance of surrogacy, IVF, procedures in facilities, thus escalating the demand for infertility treatments. Moreover, expanding number of specialized centers in emerging countries and rapid integration of advanced technologies at such facilities will propel industry demand.
 

U.S. infertility treatment devices market accounted for USD 120.4 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Advancements in infertility treatment devices, favourable regulatory environment, and growing healthcare expenditure are the key driving factors for the U.S. market trends. Additionally, the presence of non-tax agencies that provide financial aid, the prevalence of charity trusts that provide funds for infertility treatments to infertile couples, and the significant presence of well-established market players, particularly in North America, will encourage market expansion in the upcoming years.